key: cord-0876039-wfftfkam
authors: Sekhar Devulapalli, Chandra
title: COVID‐19 is milder in children possibly due to cross immunity
date: 2020-06-10
journal: Acta Paediatr
DOI: 10.1111/apa.15407
sha: 1c38284d2c77845d3c6678347c30e7b4e425eb40
doc_id: 876039
cord_uid: wfftfkam

It has been unclear why the new severe acute respiratory syndrome coronavirus (sars‐CoV‐2) hits a small minority hard, while the vast majority of children appear to be protected and develop mild or no disease (1,2). The editorial by Brodin suggests some possible mechanisms why it is so (1). I would like to emphasize the significance of cross immunity due to previous exposure to seasonal coronavirus; it may be a plausible explanation for why children appear to be protected (2,3).

Dear Editor, It has been unclear why the new severe acute respiratory syndrome coronavirus (sars-CoV-2) hits a small minority hard, while the vast majority of children appear to be protected and develop mild or no disease (1, 2) . The editorial by Brodin suggests some possible mechanisms why it is so (1). I would like to emphasize the significance of cross immunity due to previous exposure to seasonal coronavirus; it may be a plausible explanation for why children appear to be protected (2, 3) .

Seasonal coronaviruses that cause innocent colds in children lead to the formation of antibodies that last for 1-3 years. One of the four seasonal coronaviruses, human coronavirus NL63 (HCoV-NL63), also uses angiotensin converting enzyme 2 (ACE2) as a receptor. In a recent study published in March 2020 it was found that convalescent serum from patients who survived SARS could neutralize binding of the sars-CoV-2 to ACE2, thus blocking the uptake of sars-CoV-2 into the cells (3). This suggests

This article is protected by copyright. All rights reserved that there is distinct possibility of cross immunity, wherein immunity and antibody responses to one virus can have a significant effect on another (3, 4) .

to the S protein with long-lasting immunity for 8-10 years (5) . A study in 2005 showed that SARS patients developed rising titres of antibody that cross-reacted against seasonal coronaviruses. Antibodies to HCoV-NL63 increased approximately ten times. T cells are also crucial for coronavirus immunity to kill virus-infected cells. It is quite possible that long-lived memory T cells that first responded to childhood coronavirus in childhood and which can now cross-react to similar sars-CoV-2 peptide antigens (4).

To summarize, there is a clear possibility of cross-immunity against sars-CoV-2 for T and B cells that have previously protected us from seasonal coronavirus. Children probably seem to be protected from Covid-19 because they have a well-functioning or rapidly responding immune system that also does not tend to overreact to the present coronavirus family. Furthermore, the immune system in children and adolescents probably has ample experience with the viral family through exposure to regular seasonal coronavirus.

None.

Why is COVID-19 so mild in children?

Covid-19 -a mild disease in children

The coronavirus -cross immunity, herd immunity and vaccine development

Immune responses to coronaviruses with emphasis in children

Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome